{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:28:39Z","timestamp":1777627719314,"version":"3.51.4"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and Technology Research Project of Jiangxi Provincial Administration of Traditional Chinese Medicine"},{"name":"the Science and Technology Research Project of Jiangxi Provincial Department of Education"},{"name":"Jiangxi Province College Student Innovation and Entrepreneurship Training Program Project"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"\u201cDouble Thousand Plan\u201d Science and Technology Innovation High-end Talent Project of Jiangxi Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11302-025-10117-3","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T04:52:55Z","timestamp":1768798375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role and therapeutic potential of purinergic signaling pathway in metabolic syndrome-related atherosclerosis"],"prefix":"10.1007","volume":"22","author":[{"given":"Xiang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengxin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengxiao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"issue":"12","key":"10117_CR1","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.3390\/antiox12122091","volume":"12","author":"G Martemucci","year":"2023","unstructured":"Martemucci G, Fracchiolla G, Muraglia M, Tardugno R, Dibenedetto RS, D\u2019Alessandro AG (2023) Metabolic syndrome: a narrative review from the oxidative stress to the management of related diseases. Antioxidants (Basel) 12(12):2901. https:\/\/doi.org\/10.3390\/antiox12122091","journal-title":"Antioxidants (Basel)"},{"issue":"8","key":"10117_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-047849","volume":"11","author":"K Chee Cheong","year":"2021","unstructured":"Chee Cheong K, Lim KH, Ghazali SM, Teh CH, Cheah YK, Baharudin A, Lim HL, Abdul Hamid AM, Mustapha FI, Omar MA (2021) Association of metabolic syndrome with risk of cardiovascular disease mortality and all-cause mortality among Malaysian adults: a retrospective cohort study. BMJ Open 11(8):e047849. https:\/\/doi.org\/10.1136\/bmjopen-2020-047849","journal-title":"BMJ Open"},{"issue":"9","key":"10117_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097910","volume":"24","author":"E Gusev","year":"2023","unstructured":"Gusev E, Sarapultsev A (2023) Atherosclerosis and inflammation: insights from the theory of general pathological processes. Int J Mol Sci 24(9):7910. https:\/\/doi.org\/10.3390\/ijms24097910","journal-title":"Int J Mol Sci"},{"key":"10117_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176338","volume":"966","author":"A Attiq","year":"2024","unstructured":"Attiq A, Afzal S, Ahmad W, Kandeel M (2024) Hegemony of inflammation in atherosclerosis and coronary artery disease. Eur J Pharmacol 966:176338. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176338","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10117_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/biom8030080","volume":"8","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Xian X, Wang Z, Bi Y, Chen Q, Han X, Tang D, Chen R (2018) Research progress on the relationship between atherosclerosis and inflammation. Biomolecules 8(3):80. https:\/\/doi.org\/10.3390\/biom8030080","journal-title":"Biomolecules"},{"issue":"4","key":"10117_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ajpath.2023.09.012","volume":"194","author":"ME Pepin","year":"2024","unstructured":"Pepin ME, Gupta RM (2024) The role of endothelial cells in atherosclerosis: insights from genetic association studies. Am J Pathol 194(4):499\u2013509. https:\/\/doi.org\/10.1016\/j.ajpath.2023.09.012","journal-title":"Am J Pathol"},{"issue":"19","key":"10117_CR7","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1111\/bph.14779","volume":"176","author":"JL Harman","year":"2019","unstructured":"Harman JL, J\u00f8rgensen HF (2019) The role of smooth muscle cells in plaque stability: therapeutic targeting potential. Br J Pharmacol 176(19):3741\u20133753. https:\/\/doi.org\/10.1111\/bph.14779","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10117_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11302-021-09839-x","volume":"19","author":"XM Wu","year":"2023","unstructured":"Wu XM, Zhang N, Li JS, Yang ZH, Huang XL, Yang XF (2023) Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis. Purinergic Signal 19(1):265\u2013272. https:\/\/doi.org\/10.1007\/s11302-021-09839-x","journal-title":"Purinergic Signal"},{"issue":"5","key":"10117_CR9","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.4049\/jimmunol.1001298","volume":"185","author":"LM Hill","year":"2010","unstructured":"Hill LM, Gavala ML, Lenertz LY, Bertics PJ (2010) Extracellular ATP may contribute to tissue repair by rapidly stimulating purinergic receptor X7-dependent vascular endothelial growth factor release from primary human monocytes. J Immunol 185(5):3028\u20133034. https:\/\/doi.org\/10.4049\/jimmunol.1001298","journal-title":"J Immunol"},{"issue":"8","key":"10117_CR10","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nm1617","volume":"13","author":"M Idzko","year":"2007","unstructured":"Idzko M, Hammad H, van Nimwegen M, Kool M, Willart MAM, Muskens F, Hoogsteden HC, Luttmann W, Ferrari D, Di Virgilio F, Virchow JC, Lambrecht BN (2007) Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 13(8):913\u2013919. https:\/\/doi.org\/10.1038\/nm1617","journal-title":"Nat Med"},{"issue":"4","key":"10117_CR11","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.2741\/235","volume":"3","author":"MJ Bours","year":"2011","unstructured":"Bours MJ, Dagnelie PC, Giuliani AL, Wesselius A, Di Virgilio F (2011) P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation. Front Biosci Schol Ed 3(4):1443\u20131456. https:\/\/doi.org\/10.2741\/235","journal-title":"Front Biosci Schol Ed"},{"issue":"7500","key":"10117_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nature13085","volume":"509","author":"M Idzko","year":"2014","unstructured":"Idzko M, Ferrari D, Eltzschig HK (2014) Nucleotide signalling during inflammation. Nature 509(7500):310\u2013317. https:\/\/doi.org\/10.1038\/nature13085","journal-title":"Nature"},{"issue":"1","key":"10117_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1124\/pr.113.008029","volume":"66","author":"G Burnstock","year":"2014","unstructured":"Burnstock G, Ralevic V (2014) Purinergic signaling and blood vessels in health and disease. Pharmacol Rev 66(1):102\u2013192. https:\/\/doi.org\/10.1124\/pr.113.008029","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10117_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00553-z","volume":"6","author":"Z Huang","year":"2021","unstructured":"Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu SG, Huang C, Tang Y (2021) From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther 6(1):162. https:\/\/doi.org\/10.1038\/s41392-021-00553-z","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10117_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11302-017-9568-1","volume":"13","author":"Y Moriyama","year":"2017","unstructured":"Moriyama Y, Hiasa M, Sakamoto S, Omote H, Nomura M (2017) Vesicular nucleotide transporter (VNUT): appearance of an actress on the stage of purinergic signaling. Purinergic Signalling 13(3):387\u2013404. https:\/\/doi.org\/10.1007\/s11302-017-9568-1","journal-title":"Purinergic Signalling"},{"issue":"1","key":"10117_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83144-w","volume":"11","author":"N Hasuzawa","year":"2021","unstructured":"Hasuzawa N, Tatsushima K, Wang L, Kabashima M, Tokubuchi R, Nagayama A, Ashida K, Ogawa Y, Moriyama Y, Nomura M (2021) Clodronate, an inhibitor of the vesicular nucleotide transporter, ameliorates steatohepatitis and acute liver injury. Sci Rep 11(1):5192. https:\/\/doi.org\/10.1038\/s41598-021-83144-w","journal-title":"Sci Rep"},{"issue":"12","key":"10117_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2020.183408","volume":"1862","author":"N Hasuzawa","year":"2020","unstructured":"Hasuzawa N, Moriyama S, Moriyama Y, Nomura M (2020) Physiopathological roles of vesicular nucleotide transporter (VNUT), an essential component for vesicular ATP release. Biochimica et Biophysica Acta (BBA) - Biomembranes 1862(12):183408. https:\/\/doi.org\/10.1016\/j.bbamem.2020.183408","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"issue":"10","key":"10117_CR18","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1074\/jbc.M117.810168","volume":"293","author":"Y Harada","year":"2018","unstructured":"Harada Y, Kato Y, Miyaji T, Omote H, Moriyama Y, Hiasa M (2018) Vesicular nucleotide transporter mediates ATP release and migration in neutrophils. J Biol Chem 293(10):3770\u20133779. https:\/\/doi.org\/10.1074\/jbc.M117.810168","journal-title":"J Biol Chem"},{"issue":"5","key":"10117_CR19","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s10571-020-01002-1","volume":"41","author":"M Horioka","year":"2021","unstructured":"Horioka M, Ceraudo E, Lorenzen E, Sakmar TP, Huber T (2021) Purinergic receptors crosstalk with CCR5 to amplify Ca2+ signaling. Cell Mol Neurobiol 41(5):1085\u20131101. https:\/\/doi.org\/10.1007\/s10571-020-01002-1","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"10117_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","volume":"8","author":"H Zimmermann","year":"2012","unstructured":"Zimmermann H, Zebisch M, Str\u00e4ter N (2012) Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal 8(3):437\u2013502. https:\/\/doi.org\/10.1007\/s11302-012-9309-4","journal-title":"Purinergic Signal"},{"issue":"11","key":"10117_CR21","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.3390\/cells9112496","volume":"9","author":"V Vultaggio-Poma","year":"2020","unstructured":"Vultaggio-Poma V, Sarti AC, Di Virgilio F (2020) Extracellular ATP: a feasible target for cancer therapy. Cells 9(11):2496. https:\/\/doi.org\/10.3390\/cells9112496","journal-title":"Cells"},{"issue":"7","key":"10117_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073503","volume":"22","author":"R Van Campenhout","year":"2021","unstructured":"Van Campenhout R, Gomes AR, De Groof TWM, Muyldermans S, Devoogdt N, Vinken M (2021) Mechanisms underlying connexin hemichannel activation in disease. Int J Mol Sci 22(7):3503. https:\/\/doi.org\/10.3390\/ijms22073503","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10117_CR23","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1007\/s10571-023-01415-8","volume":"43","author":"E Czuba-Paku\u0142a","year":"2023","unstructured":"Czuba-Paku\u0142a E, Pelikant-Ma\u0142ecka I, Lietzau G, W\u00f3jcik S, Smole\u0144ski RT, Kowia\u0144ski P (2023) Accelerated extracellular nucleotide metabolism in brain microvascular endothelial cells in experimental hypercholesterolemia. Cell Mol Neurobiol 43(8):4245\u20134259. https:\/\/doi.org\/10.1007\/s10571-023-01415-8","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"10117_CR24","doi-asserted-by":"publisher","first-page":"e1007903","DOI":"10.1371\/journal.pcbi.1007903","volume":"16","author":"JM Briggs","year":"2020","unstructured":"Briggs JM, Rahmaninejad H, Pace T, Bhatt S, Sun B, Kekenes-Huskey P (2020) Co-localization and confinement of ecto-nucleotidases modulate extracellular adenosine nucleotide distributions. PLoS Comput Biol 16(6):e1007903. https:\/\/doi.org\/10.1371\/journal.pcbi.1007903","journal-title":"PLoS Comput Biol"},{"key":"10117_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.exer.2018.02.019","volume":"170","author":"K-I Nakashima","year":"2018","unstructured":"Nakashima K-I, Iwao K, Inoue T, Haga A, Tsutsumi T, Mochita MI, Fujimoto T, Tanihara H (2018) Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells. Exp Eye Res 170:160\u2013168. https:\/\/doi.org\/10.1016\/j.exer.2018.02.019","journal-title":"Exp Eye Res"},{"issue":"1","key":"10117_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1124\/pr.58.1.5","volume":"58","author":"G Burnstock","year":"2006","unstructured":"Burnstock G (2006) Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58(1):58\u201386. https:\/\/doi.org\/10.1124\/pr.58.1.5","journal-title":"Pharmacol Rev"},{"issue":"11","key":"10117_CR27","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1111\/bph.15005","volume":"177","author":"KA Jacobson","year":"2020","unstructured":"Jacobson KA, Delicado EG, Gachet C, Kennedy C, von K\u00fcgelgen I, Li B, Miras\u2010Portugal MT, Novak I, Sch\u00f6neberg T, Perez\u2010Sen R, Thor D, Wu B, Yang Z, M\u00fcller CE (2020) Update of P2Y receptor pharmacology: IUPHAR review 27. Br J Pharmacol 177(11):2413\u20132433. https:\/\/doi.org\/10.1111\/bph.15005","journal-title":"Br J Pharmacol"},{"key":"10117_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114419","volume":"187","author":"M Lov\u00e1szi","year":"2021","unstructured":"Lov\u00e1szi M, Branco Haas C, Antonioli L, Pacher P, Hask\u00f3 G (2021) The role of P2Y receptors in regulating immunity and metabolism. Biochem Pharmacol 187:114419. https:\/\/doi.org\/10.1016\/j.bcp.2021.114419","journal-title":"Biochem Pharmacol"},{"key":"10117_CR29","doi-asserted-by":"publisher","first-page":"114361","DOI":"10.1016\/j.bcp.2020.114361","volume":"187","author":"I von K\u00fcgelgen","year":"2021","unstructured":"von K\u00fcgelgen I (2021) Molecular pharmacology of P2Y receptor subtypes. Biochem Pharmacol 187:114361. https:\/\/doi.org\/10.1016\/j.bcp.2020.114361","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10117_CR30","doi-asserted-by":"publisher","first-page":"H723","DOI":"10.1152\/ajpheart.00417.2020","volume":"319","author":"B Wernly","year":"2020","unstructured":"Wernly B, Zhou Z (2020) More purinergic receptors deserve attention as therapeutic targets for the treatment of cardiovascular disease. Am J Physiol Heart Circ Physiol 319(4):H723-h729. https:\/\/doi.org\/10.1152\/ajpheart.00417.2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"10117_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051366","volume":"9","author":"R Guieu","year":"2020","unstructured":"Guieu R, Deharo J-C, Maille B, Crotti L, Torresani E, Brignole M, Parati G (2020) Adenosine and the cardiovascular system: the good and the bad. J Clin Med 9(5):1366. https:\/\/doi.org\/10.3390\/jcm9051366","journal-title":"J Clin Med"},{"issue":"1","key":"10117_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/circresaha.116.309726","volume":"120","author":"G Burnstock","year":"2017","unstructured":"Burnstock G (2017) Purinergic signaling in the cardiovascular system. Circ Res 120(1):207\u2013228. https:\/\/doi.org\/10.1161\/circresaha.116.309726","journal-title":"Circ Res"},{"key":"10117_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2015.00060","volume":"2","author":"R Sluyter","year":"2015","unstructured":"Sluyter R (2015) P2X and P2Y receptor signaling in red blood cells. Front Mol Biosci 2:60. https:\/\/doi.org\/10.3389\/fmolb.2015.00060","journal-title":"Front Mol Biosci"},{"issue":"3","key":"10117_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11302-011-9247-6","volume":"7","author":"B Hechler","year":"2011","unstructured":"Hechler B, Gachet C (2011) P2 receptors and platelet function. Purinergic Signal 7(3):293\u2013303. https:\/\/doi.org\/10.1007\/s11302-011-9247-6","journal-title":"Purinergic Signal"},{"issue":"10","key":"10117_CR35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","volume":"18","author":"F Di Virgilio","year":"2018","unstructured":"Di Virgilio F, Sarti AC, Falzoni S, De Marchi E, Adinolfi E (2018) Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer 18(10):601\u2013618. https:\/\/doi.org\/10.1038\/s41568-018-0037-0","journal-title":"Nat Rev Cancer"},{"key":"10117_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trsl.2017.01.001","volume":"183","author":"JD Tune","year":"2017","unstructured":"Tune JD, Goodwill AG, Sassoon DJ, Mather KJ (2017) Cardiovascular consequences of metabolic syndrome. Transl Res 183:57\u201370. https:\/\/doi.org\/10.1016\/j.trsl.2017.01.001","journal-title":"Transl Res"},{"issue":"5","key":"10117_CR37","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00018-022-04286-2","volume":"79","author":"L Liu","year":"2022","unstructured":"Liu L, Shi Z, Ji X, Zhang W, Luan J, Zahr T, Qiang L (2022) Adipokines, adiposity, and atherosclerosis. Cell Mol Life Sci 79(5):272. https:\/\/doi.org\/10.1007\/s00018-022-04286-2","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10117_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03544-8","volume":"12","author":"G Wang","year":"2021","unstructured":"Wang G, Chen JJ, Deng WY, Ren K, Yin SH, Yu XH (2021) CTRP12 ameliorates atherosclerosis by promoting cholesterol efflux and inhibiting inflammatory response via the miR-155-5p\/LXR\u03b1 pathway. Cell Death Dis 12(3):254. https:\/\/doi.org\/10.1038\/s41419-021-03544-8","journal-title":"Cell Death Dis"},{"key":"10117_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.585887","volume":"12","author":"M Obradovic","year":"2021","unstructured":"Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, Gojobori T, Isenovic ER (2021) Leptin and obesity: role and clinical implication. Front Endocrinol (Lausanne) 12:585887. https:\/\/doi.org\/10.3389\/fendo.2021.585887","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10117_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1006\/cimm.1999.1490","volume":"194","author":"J Santos-Alvarez","year":"1999","unstructured":"Santos-Alvarez J, Goberna R, S\u00e1nchez-Margalet V (1999) Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 194(1):6\u201311. https:\/\/doi.org\/10.1006\/cimm.1999.1490","journal-title":"Cell Immunol"},{"issue":"7","key":"10117_CR41","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1161\/circulationaha.106.618918","volume":"114","author":"N Sattar","year":"2006","unstructured":"Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, Danesh J, Whincup PH (2006) Adiponectin and coronary heart disease. Circulation 114(7):623\u2013629. https:\/\/doi.org\/10.1161\/circulationaha.106.618918","journal-title":"Circulation"},{"issue":"16","key":"10117_CR42","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1093\/eurheartj\/ehi340","volume":"26","author":"D Rothenbacher","year":"2005","unstructured":"Rothenbacher D, Brenner H, M\u00e4rz W, Koenig W (2005) Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J 26(16):1640\u20131646. https:\/\/doi.org\/10.1093\/eurheartj\/ehi340","journal-title":"Eur Heart J"},{"key":"10117_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-016-0202-y","volume":"15","author":"X Wang","year":"2016","unstructured":"Wang X, Chen Q, Pu H, Wei Q, Duan M, Zhang C, Jiang T, Shou X, Zhang J, Yang Y (2016) Adiponectin improves NF-\u03baB-mediated inflammation and abates atherosclerosis progression in apolipoprotein E-deficient mice. Lipids Health Dis 15:33. https:\/\/doi.org\/10.1186\/s12944-016-0202-y","journal-title":"Lipids Health Dis"},{"key":"10117_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156591","volume":"178","author":"X Liu","year":"2024","unstructured":"Liu X, Dong M, Li T, Wang J (2024) Correlation of circulating fibroblast growth factor 21 levels with inflammatory factors and the degree of coronary artery stenosis in patients with acute myocardial infarction. Cytokine 178:156591. https:\/\/doi.org\/10.1016\/j.cyto.2024.156591","journal-title":"Cytokine"},{"key":"10117_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.818890","volume":"9","author":"Y Feng","year":"2022","unstructured":"Feng Y, Ye D, Wang Z, Pan H, Lu X, Wang M, Xu Y, Yu J, Zhang J, Zhao M, Xu S, Pan W, Yin Z, Ye J, Wan J (2022) The role of interleukin-6 family members in cardiovascular diseases. Front Cardiovasc Med 9:818890. https:\/\/doi.org\/10.3389\/fcvm.2022.818890","journal-title":"Front Cardiovasc Med"},{"key":"10117_CR46","doi-asserted-by":"publisher","first-page":"1235953","DOI":"10.3389\/fcvm.2023.1235953","volume":"10","author":"J Luo","year":"2023","unstructured":"Luo J, He Z, Li Q, Lv M, Cai Y, Ke W, Niu X, Zhang Z (2023) Adipokines in atherosclerosis: unraveling complex roles. Front Cardiovasc Med 10:1235953. https:\/\/doi.org\/10.3389\/fcvm.2023.1235953","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10117_CR47","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.2337\/diabetes.52.11.2795","volume":"52","author":"L Quagliaro","year":"2003","unstructured":"Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A (2003) Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52(11):2795\u20132804. https:\/\/doi.org\/10.2337\/diabetes.52.11.2795","journal-title":"Diabetes"},{"issue":"6","key":"10117_CR48","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/hypertensionaha.115.06015","volume":"66","author":"G Jia","year":"2015","unstructured":"Jia G, Habibi J, DeMarco VG, Martinez-Lemus LA, Ma L, Whaley-Connell AT, Aroor AR, Domeier TL, Zhu Y, Meininger GA, Mueller KB, Jaffe IZ, Sowers JR (2015) Endothelial mineralocorticoid receptor deletion prevents diet-induced cardiac diastolic dysfunction in females. Hypertension 66(6):1159\u20131167. https:\/\/doi.org\/10.1161\/hypertensionaha.115.06015","journal-title":"Hypertension"},{"issue":"6","key":"10117_CR49","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1210\/er.2018-00141","volume":"40","author":"A Di Pino","year":"2019","unstructured":"Di Pino A, DeFronzo RA (2019) Insulin resistance and atherosclerosis: implications for insulin-sensitizing agents. Endocr Rev 40(6):1447\u20131467. https:\/\/doi.org\/10.1210\/er.2018-00141","journal-title":"Endocr Rev"},{"issue":"7","key":"10117_CR50","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1161\/01.atv.18.7.1093","volume":"18","author":"R Scalia","year":"1998","unstructured":"Scalia R, Appel JZ, Lefer AM (1998) Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1. Arterioscler Thromb Vasc Biol 18(7):1093\u20131100. https:\/\/doi.org\/10.1161\/01.atv.18.7.1093","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10117_CR51","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/eji.201545676","volume":"46","author":"S Freigang","year":"2016","unstructured":"Freigang S (2016) The regulation of inflammation by oxidized phospholipids. Eur J Immunol 46(8):1818\u20131825. https:\/\/doi.org\/10.1002\/eji.201545676","journal-title":"Eur J Immunol"},{"key":"10117_CR52","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.freeradbiomed.2019.03.036","volume":"144","author":"S Zhong","year":"2019","unstructured":"Zhong S, Li L, Shen X, Li Q, Xu W, Wang X, Tao Y, Yin H (2019) An update on lipid oxidation and inflammation in cardiovascular diseases. Free Radic Biol Med 144:266\u2013278. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.03.036","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10117_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s43152-020-00017-6","volume":"1","author":"S Kaul","year":"2020","unstructured":"Kaul S, Methner C, Mishra A (2020) The role of pericytes in hyperemia-induced capillary de-recruitment following stenosis. Curr Tissue Microenviron Rep 1(4):163\u2013169. https:\/\/doi.org\/10.1007\/s43152-020-00017-6","journal-title":"Curr Tissue Microenviron Rep"},{"issue":"8","key":"10117_CR54","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.jdiacomp.2016.08.005","volume":"30","author":"N Warmke","year":"2016","unstructured":"Warmke N, Griffin KJ, Cubbon RM (2016) Pericytes in diabetes-associated vascular disease. J Diabetes Complications 30(8):1643\u20131650. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.08.005","journal-title":"J Diabetes Complications"},{"issue":"1","key":"10117_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12989-020-00391-x","volume":"17","author":"S Liang","year":"2020","unstructured":"Liang S, Zhang J, Ning R, Du Z, Liu J, Batibawa JW, Duan J, Sun Z (2020) The critical role of endothelial function in fine particulate matter-induced atherosclerosis. Part Fibre Toxicol 17(1):61. https:\/\/doi.org\/10.1186\/s12989-020-00391-x","journal-title":"Part Fibre Toxicol"},{"issue":"3","key":"10117_CR56","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.molmed.2014.12.008","volume":"21","author":"D Ferrari","year":"2015","unstructured":"Ferrari D, Vitiello L, Idzko M, la Sa A (2015) Purinergic signaling in atherosclerosis. Trends Mol Med 21(3):184\u2013192. https:\/\/doi.org\/10.1016\/j.molmed.2014.12.008","journal-title":"Trends Mol Med"},{"key":"10117_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.925923","volume":"9","author":"H Jiang","year":"2022","unstructured":"Jiang H, Zhou Y, Nabavi SM, Sahebkar A, Little PJ, Xu S, Weng J, Ge J (2022) Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis. Front Cardiovasc Med 9:925923. https:\/\/doi.org\/10.3389\/fcvm.2022.925923","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10117_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-9-41","volume":"9","author":"H Pohjant\u00e4hti-Maaroos","year":"2010","unstructured":"Pohjant\u00e4hti-Maaroos H, Palom\u00e4ki A, Kankkunen P, Laitinen R, Husgafvel S, Oksanen K (2010) Circulating oxidized low-density lipoproteins and arterial elasticity: comparison between men with metabolic syndrome and physically active counterparts. Cardiovasc Diabetol 9(1):41. https:\/\/doi.org\/10.1186\/1475-2840-9-41","journal-title":"Cardiovasc Diabetol"},{"key":"10117_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2014.01.022","volume":"69","author":"SY Eun","year":"2014","unstructured":"Eun SY, Park SW, Lee JH, Chang KC, Kim HJ (2014) P2Y(2)r activation by nucleotides released from oxLDL-treated endothelial cells (ECs) mediates the interaction between ECs and immune cells through RAGE expression and reactive oxygen species production. Free Radic Biol Med 69:157\u2013166. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.01.022","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10117_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020226","volume":"10","author":"S Gencer","year":"2021","unstructured":"Gencer S, Evans BR, van der Vorst EPC, D\u00f6ring Y, Weber C (2021) Inflammatory chemokines in atherosclerosis. Cells 10(2):226. https:\/\/doi.org\/10.3390\/cells10020226","journal-title":"Cells"},{"issue":"1","key":"10117_CR61","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/atvbaha.116.308561","volume":"37","author":"X Chen","year":"2017","unstructured":"Chen X, Qian S, Hoggatt A, Tang H, Hacker TA, Obukhov AG, Herring PB, Seye CI (2017) Endothelial cell-specific deletion of P2Y2 receptor promotes plaque stability in atherosclerosis-susceptible ApoE-null mice. Arterioscler Thromb Vasc Biol 37(1):75\u201383. https:\/\/doi.org\/10.1161\/atvbaha.116.308561","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10117_CR62","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1084\/jem.20180483","volume":"215","author":"J Albarr\u00e1n-Ju\u00e1rez","year":"2018","unstructured":"Albarr\u00e1n-Ju\u00e1rez J, Iring A, Wang S, Joseph S, Grimm M, Strilic B, Wettschureck N, Althoff TF, Offermanns S (2018) Piezo1 and G(q)\/G(11) promote endothelial inflammation depending on flow pattern and integrin activation. J Exp Med 215(10):2655\u20132672. https:\/\/doi.org\/10.1084\/jem.20180483","journal-title":"J Exp Med"},{"key":"10117_CR63","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2016.12.014","volume":"257","author":"S Qian","year":"2017","unstructured":"Qian S, Regan JN, Shelton MT, Hoggatt A, Mohammad KS, Herring PB, Seye CI (2017) The P2Y(2) nucleotide receptor is an inhibitor of vascular calcification. Atherosclerosis 257:38\u201346. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.12.014","journal-title":"Atherosclerosis"},{"issue":"28","key":"10117_CR64","doi-asserted-by":"publisher","first-page":"21303","DOI":"10.1074\/jbc.M110.120790","volume":"285","author":"Z Wang","year":"2010","unstructured":"Wang Z, Ginnan R, Abdullaev IF, Trebak M, Vincent PA, Singer HA (2010) Calcium\/calmodulin-dependent protein kinase II delta 6 (CaMKIIdelta6) and RhoA involvement in thrombin-induced endothelial barrier dysfunction. J Biol Chem 285(28):21303\u201321312. https:\/\/doi.org\/10.1074\/jbc.M110.120790","journal-title":"J Biol Chem"},{"issue":"10","key":"10117_CR65","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1161\/atvbaha.114.303585","volume":"34","author":"P Stachon","year":"2014","unstructured":"Stachon P, Peikert A, Michel NA, Hergeth S, Marchini T, Wolf D, Dufner B, Hoppe N, Ayata CK, Grimm M, Cicko S, Schulte L, Rein\u00f6hl J, von zurMuhlen C, Bode C, Idzko M, Zirlik A (2014) P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 34(10):2237\u20132245. https:\/\/doi.org\/10.1161\/atvbaha.114.303585","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10117_CR66","doi-asserted-by":"publisher","first-page":"177513","DOI":"10.1016\/j.ejphar.2025.177513","volume":"998","author":"L Li","year":"2025","unstructured":"Li L, Lai L, Qiu D, Ding Y, Yu M, Zhang T, Wang Z, Wang S (2025) P2Y(6) receptor: a promising therapeutic target for atherosclerosis. Eur J Pharmacol 998:177513. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177513","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10117_CR67","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/atvbaha.109.194902","volume":"30","author":"S Gessi","year":"2010","unstructured":"Gessi S, Fogli E, Sacchetto V, Merighi S, Varani K, Preti D, Leung E, Maclennan S, Borea PA (2010) Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells. Arterioscler Thromb Vasc Biol 30(1):90\u201397. https:\/\/doi.org\/10.1161\/atvbaha.109.194902","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10117_CR68","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1194\/jlr.M072132","volume":"58","author":"M De Giorgi","year":"2017","unstructured":"De Giorgi M, Enjyoji K, Jiang G, Csizmadia E, Mitsuhashi S, Gumina RJ, Smolenski RT, Robson SC (2017) Complete deletion of Cd39 is atheroprotective in apolipoprotein E-deficient mice. J Lipid Res 58(7):1292\u20131305. https:\/\/doi.org\/10.1194\/jlr.M072132","journal-title":"J Lipid Res"},{"issue":"4","key":"10117_CR69","doi-asserted-by":"publisher","first-page":"e95807","DOI":"10.1371\/journal.pone.0095807","volume":"9","author":"M Goffinet","year":"2014","unstructured":"Goffinet M, Tardy C, Boubekeur N, Cholez G, Bluteau A, Oniciu DC, Lalwani ND, Dasseux JL, Barbaras R, Baron R (2014) P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo. PLoS ONE 9(4):e95807. https:\/\/doi.org\/10.1371\/journal.pone.0095807","journal-title":"PLoS ONE"},{"issue":"2","key":"10117_CR70","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/cvr\/cvv109","volume":"106","author":"L Lichtenstein","year":"2015","unstructured":"Lichtenstein L, Serhan N, Espinosa-Delgado S, Fabre A, Annema W, Tietge UJ, Robaye B, Boeynaems JM, Laffargue M, Perret B, Martinez LO (2015) Increased atherosclerosis in P2Y13\/apolipoprotein E double-knockout mice: contribution of P2Y13 to reverse cholesterol transport. Cardiovasc Res 106(2):314\u2013323. https:\/\/doi.org\/10.1093\/cvr\/cvv109","journal-title":"Cardiovasc Res"},{"key":"10117_CR71","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.175623","author":"T Duparc","year":"2024","unstructured":"Duparc T, Gore E, Combes G, Beuzelin D, Pires Da Silva J, Bouguetoch V, Marqu\u00e8s MA, Velazquez A, Viguerie N, Tavernier G, Arner P, Ryd\u00e9n M, Langin D, Sioufi N, Nasser M, Cabou C, Najib S, Martinez LO (2024) P2Y13 receptor deficiency favors adipose tissue lipolysis and worsens insulin resistance and fatty liver disease. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.175623","journal-title":"JCI Insight"},{"issue":"2","key":"10117_CR72","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/cvr\/cvr218","volume":"92","author":"A Buchheiser","year":"2011","unstructured":"Buchheiser A, Ebner A, Burghoff S, Ding Z, Romio M, Viethen C, Lindecke A, K\u00f6hrer K, Fischer JW, Schrader J (2011) Inactivation of CD73 promotes atherogenesis in apolipoprotein E-deficient mice. Cardiovasc Res 92(2):338\u2013347. https:\/\/doi.org\/10.1093\/cvr\/cvr218","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10117_CR73","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/atvbaha.109.188839","volume":"29","author":"H Wang","year":"2009","unstructured":"Wang H, Zhang W, Zhu C, Bucher C, Blazar BR, Zhang C, Chen JF, Linden J, Wu C, Huo Y (2009) Inactivation of the adenosine A2A receptor protects apolipoprotein E-deficient mice from atherosclerosis. Arterioscler Thromb Vasc Biol 29(7):1046\u20131052. https:\/\/doi.org\/10.1161\/atvbaha.109.188839","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10117_CR74","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1189\/jlb.0709513","volume":"87","author":"TC Bingham","year":"2010","unstructured":"Bingham TC, Fisher EA, Parathath S, Reiss AB, Chan ES, Cronstein BN (2010) A2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol efflux. J Leukoc Biol 87(4):683\u2013690. https:\/\/doi.org\/10.1189\/jlb.0709513","journal-title":"J Leukoc Biol"},{"key":"10117_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107156","volume":"203","author":"Y Cai","year":"2024","unstructured":"Cai Y, Zhou Y, Yang Q, Xu J, Da Q, Ma Q, Zhao D, Lu T, Kim HW, Fulton D, Jiang X, Weintraub NL, Dong K, Xu S, Hong M, Liu Z, Huo Y (2024) Blockade of endothelial adenosine receptor 2 A suppresses atherosclerosis in vivo through inhibiting CREB-ALK5-mediated endothelial to mesenchymal transition. Pharmacol Res 203:107156. https:\/\/doi.org\/10.1016\/j.phrs.2024.107156","journal-title":"Pharmacol Res"},{"issue":"2","key":"10117_CR76","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1073\/pnas.0705563105","volume":"105","author":"D Yang","year":"2008","unstructured":"Yang D, Koupenova M, McCrann DJ, Kopeikina KJ, Kagan HM, Schreiber BM, Ravid K (2008) The A2b adenosine receptor protects against vascular injury. Proc Natl Acad Sci U S A 105(2):792\u2013796. https:\/\/doi.org\/10.1073\/pnas.0705563105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10117_CR77","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/circulationaha.111.057596","volume":"125","author":"M Koupenova","year":"2012","unstructured":"Koupenova M, Johnston-Cox H, Vezeridis A, Gavras H, Yang D, Zannis V, Ravid K (2012) A2b adenosine receptor regulates hyperlipidemia and atherosclerosis. Circulation 125(2):354\u2013363. https:\/\/doi.org\/10.1161\/circulationaha.111.057596","journal-title":"Circulation"},{"issue":"21","key":"10117_CR78","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/circulationaha.110.002139","volume":"123","author":"M Zerr","year":"2011","unstructured":"Zerr M, Hechler B, Freund M, Magnenat S, Lanois I, Cazenave J-P, L\u00e9on C, Gachet C (2011) Major contribution of the P2Y1 receptor in purinergic regulation of TNF\u03b1-induced vascular inflammation. Circulation 123(21):2404\u20132413. https:\/\/doi.org\/10.1161\/circulationaha.110.002139","journal-title":"Circulation"},{"issue":"18","key":"10117_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186855","volume":"21","author":"D Strassheim","year":"2020","unstructured":"Strassheim D, Verin A, Batori R, Nijmeh H, Burns N, Kovacs-Kasa A, Umapathy NS, Kotamarthi J, Gokhale YS, Karoor V, Stenmark KR, Gerasimovskaya E (2020) P2Y purinergic receptors, endothelial dysfunction, and cardiovascular diseases. Int J Mol Sci 21(18):6855. https:\/\/doi.org\/10.3390\/ijms21186855","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10117_CR80","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/circresaha.107.165795","volume":"102","author":"J Shen","year":"2008","unstructured":"Shen J, DiCorleto PE (2008) ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways. Circ Res 102(4):448\u2013456. https:\/\/doi.org\/10.1161\/circresaha.107.165795","journal-title":"Circ Res"},{"issue":"2","key":"10117_CR81","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1159\/000477607","volume":"42","author":"A Castaing-Berthou","year":"2017","unstructured":"Castaing-Berthou A, Malet N, Radojkovic C, Cabou C, Gayral S, Martinez LO, Laffargue M (2017) PI3K\u03b2 plays a key role in apolipoprotein A-I-induced endothelial cell proliferation through activation of the Ecto-F1-ATPase\/P2Y1 receptors. Cell Physiol Biochem 42(2):579\u2013593. https:\/\/doi.org\/10.1159\/000477607","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"10117_CR82","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13268","volume":"226","author":"C Cabou","year":"2019","unstructured":"Cabou C, Honorato P, Brice\u00f1o L, Ghezali L, Duparc T, Le\u00f3n M, Combes G, Frayssinhes L, Fournel A, Abot A, Masri B, Parada N, Aguilera V, Aguayo C, Knauf C, Gonz\u00e1lez M, Radojkovic C, Martinez LO (2019) Pharmacological inhibition of the F(1) -ATPase\/P2Y(1) pathway suppresses the effect of apolipoprotein A1 on endothelial nitric oxide synthesis and vasorelaxation. Acta Physiol (Oxf) 226(3):e13268. https:\/\/doi.org\/10.1111\/apha.13268","journal-title":"Acta Physiol (Oxf)"},{"issue":"25","key":"10117_CR83","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1161\/circulationaha.117.027400","volume":"135","author":"P Stachon","year":"2017","unstructured":"Stachon P, Heidenreich A, Merz J, Hilgendorf I, Wolf D, Willecke F, von Garlen S, Albrecht P, H\u00e4rdtner C, Ehrat N, Hoppe N, Rein\u00f6hl J, von ZurM\u00fchlen C, Bode C, Idzko M, Zirlik A (2017) P2X(7) deficiency blocks lesional inflammasome activity and ameliorates atherosclerosis in mice. Circulation 135(25):2524\u20132533. https:\/\/doi.org\/10.1161\/circulationaha.117.027400","journal-title":"Circulation"},{"issue":"1","key":"10117_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05137-y","volume":"7","author":"M Lombardi","year":"2017","unstructured":"Lombardi M, Mantione ME, Baccellieri D, Ferrara D, Castellano R, Chiesa R, Alfieri O, Foglieni C (2017) P2X7 receptor antagonism modulates IL-1\u03b2 and MMP9 in human atherosclerotic vessels. Sci Rep 7(1):4872. https:\/\/doi.org\/10.1038\/s41598-017-05137-y","journal-title":"Sci Rep"},{"key":"10117_CR85","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ijcard.2018.12.047","volume":"278","author":"ME Mantione","year":"2019","unstructured":"Mantione ME, Lombardi M, Baccellieri D, Ferrara D, Castellano R, Chiesa R, Alfieri O, Foglieni C (2019) IL-1\u03b2\/MMP9 activation in primary human vascular smooth muscle-like cells: exploring the role of TNF\u03b1 and P2X7. Int J Cardiol 278:202\u2013209. https:\/\/doi.org\/10.1016\/j.ijcard.2018.12.047","journal-title":"Int J Cardiol"},{"issue":"1","key":"10117_CR86","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbrc.2007.10.148","volume":"365","author":"O Mistafa","year":"2008","unstructured":"Mistafa O, H\u00f6gberg J, Stenius U (2008) Statins and ATP regulate nuclear pAkt via the P2X7 purinergic receptor in epithelial cells. Biochem Biophys Res Commun 365(1):131\u2013136. https:\/\/doi.org\/10.1016\/j.bbrc.2007.10.148","journal-title":"Biochem Biophys Res Commun"},{"key":"10117_CR87","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cca.2018.01.032","volume":"479","author":"Z Chen","year":"2018","unstructured":"Chen Z, He L, Li L, Chen L (2018) The P2X7 purinergic receptor: an emerging therapeutic target in cardiovascular diseases. Clin Chim Acta 479:196\u2013207. https:\/\/doi.org\/10.1016\/j.cca.2018.01.032","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10117_CR88","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00018-018-2937-2","volume":"76","author":"Y Gao","year":"2019","unstructured":"Gao Y, Yu C, Pi S, Mao L, Hu B (2019) The role of P2Y(12) receptor in ischemic stroke of atherosclerotic origin. Cell Mol Life Sci 76(2):341\u2013354. https:\/\/doi.org\/10.1007\/s00018-018-2937-2","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10117_CR89","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1080\/15548627.2020.1741202","volume":"17","author":"S Pi","year":"2021","unstructured":"Pi S, Mao L, Chen J, Shi H, Liu Y, Guo X, Li Y, Zhou L, He H, Yu C, Liu J, Dang Y, Xia Y, He Q, Jin H, Li Y, Hu Y, Miao Y, Yue Z, Hu B (2021) The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis. Autophagy 17(4):980\u20131000. https:\/\/doi.org\/10.1080\/15548627.2020.1741202","journal-title":"Autophagy"},{"issue":"1","key":"10117_CR90","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1161\/atvbaha.111.238063","volume":"32","author":"C Cavelier","year":"2012","unstructured":"Cavelier C, Ohnsorg PM, Rohrer L, von Eckardstein A (2012) The \u03b2-chain of cell surface F(0)F(1) ATPase modulates apoA-I and HDL transcytosis through aortic endothelial cells. Arterioscler Thromb Vasc Biol 32(1):131\u2013139. https:\/\/doi.org\/10.1161\/atvbaha.111.238063","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10117_CR91","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11239-012-0737-3","volume":"34","author":"DJ Angiolillo","year":"2012","unstructured":"Angiolillo DJ, Schneider DJ, Bhatt DL, French WJ, Price MJ, Saucedo JF, Shaburishvili T, Huber K, Prats J, Liu T, Harrington RA, Becker RC (2012) Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials. J Thromb Thrombolysis 34(1):44\u201355. https:\/\/doi.org\/10.1007\/s11239-012-0737-3","journal-title":"J Thromb Thrombolysis"},{"issue":"5","key":"10117_CR92","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00380-015-0696-7","volume":"31","author":"C Heim","year":"2016","unstructured":"Heim C, Gebhardt J, Ramsperger-Gleixner M, Jacobi J, Weyand M, Ensminger SM (2016) Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo. Heart Vessels 31(5):783\u2013794. https:\/\/doi.org\/10.1007\/s00380-015-0696-7","journal-title":"Heart Vessels"},{"key":"10117_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2024.109602","volume":"127","author":"MF Vera Castro","year":"2024","unstructured":"Vera Castro MF, Assmann CE, Reichert KP, Coppetti PM, Stefanello N, da Silva AD, Mostardeiro VB, de Jesus LB, da Silveira MV, Schirmann AA, Fracasso M, Maciel RM, Morsch VMM, Schetinger MRC (2024) Vitamin D3 mitigates type 2 diabetes induced by a high carbohydrate-high fat diet in rats: role of the purinergic system. J Nutr Biochem 127:109602. https:\/\/doi.org\/10.1016\/j.jnutbio.2024.109602","journal-title":"J Nutr Biochem"},{"issue":"10","key":"10117_CR94","doi-asserted-by":"publisher","first-page":"520","DOI":"10.5483\/BMBRep.2018.51.10.098","volume":"51","author":"JG Park","year":"2018","unstructured":"Park JG, Jeong SJ, Yu J, Kim G, Jeong LS, Oh GT (2018) LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice. BMB Rep 51(10):520\u2013525. https:\/\/doi.org\/10.5483\/BMBRep.2018.51.10.098","journal-title":"BMB Rep"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-025-10117-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-025-10117-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-025-10117-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T22:06:45Z","timestamp":1771884405000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-025-10117-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10117"],"URL":"https:\/\/doi.org\/10.1007\/s11302-025-10117-3","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"7"}}